These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 38796701)
1. Decoding the specificity of m Cun Y; Guo W; Ma B; Okuno Y; Wang J Mol Ther; 2024 Aug; 32(8):2461-2469. PubMed ID: 38796701 [TBL] [Abstract][Full Text] [Related]
2. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919 [TBL] [Abstract][Full Text] [Related]
3. The role of m Chen XY; Zhang J; Zhu JS Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332 [TBL] [Abstract][Full Text] [Related]
4. Modulation of m Han J; Song Y; Xie J; Tano V; Shen H; Gan WL; Ng L; Ng BYL; Ng VHE; Sui X; Tang SJ; Chen L Proc Natl Acad Sci U S A; 2024 Oct; 121(40):e2404509121. PubMed ID: 39316047 [TBL] [Abstract][Full Text] [Related]
5. Roles of N Wang X; Xie H; Ying Y; Chen D; Li J J Cell Mol Med; 2020 Sep; 24(18):10302-10310. PubMed ID: 32808488 [TBL] [Abstract][Full Text] [Related]
6. Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression. Liu R; Jia Y; Kong G; He A J Cancer Res Clin Oncol; 2022 Sep; 148(9):2215-2230. PubMed ID: 35763107 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Liang Z; Kidwell RL; Deng H; Xie Q Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573 [TBL] [Abstract][Full Text] [Related]
8. Biological roles of the RNA m Hong J; Xu K; Lee JH Exp Mol Med; 2022 Nov; 54(11):1822-1832. PubMed ID: 36446846 [TBL] [Abstract][Full Text] [Related]
9. N Hu BB; Wang XY; Gu XY; Zou C; Gao ZJ; Zhang H; Fan Y Mol Cancer; 2019 Dec; 18(1):178. PubMed ID: 31810483 [TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury. Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678 [TBL] [Abstract][Full Text] [Related]
11. RNA methylation: A potential therapeutic target in autoimmune disease. Li L; Xia X; Yang T; Sun Y; Liu X; Xu W; Lu M; Cui D; Wu Y Int Rev Immunol; 2024 May; 43(3):160-177. PubMed ID: 37975549 [TBL] [Abstract][Full Text] [Related]
14. N von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994 [TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J Front Immunol; 2021; 12():773570. PubMed ID: 34956201 [TBL] [Abstract][Full Text] [Related]
16. The m Romanowska K; Rawłuszko-Wieczorek AA; Marczak Ł; Kosińska A; Suchorska WM; Golusiński W Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207099 [TBL] [Abstract][Full Text] [Related]
17. Novel insights into the interplay between m Yi YC; Chen XY; Zhang J; Zhu JS Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982 [TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer. Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750 [TBL] [Abstract][Full Text] [Related]
19. Regulation of Gene Expression by N Liu J; Harada BT; He C Trends Cell Biol; 2019 Jun; 29(6):487-499. PubMed ID: 30940398 [TBL] [Abstract][Full Text] [Related]
20. Cross-talk among writers, readers, and erasers of m Panneerdoss S; Eedunuri VK; Yadav P; Timilsina S; Rajamanickam S; Viswanadhapalli S; Abdelfattah N; Onyeagucha BC; Cui X; Lai Z; Mohammad TA; Gupta YK; Huang TH; Huang Y; Chen Y; Rao MK Sci Adv; 2018 Oct; 4(10):eaar8263. PubMed ID: 30306128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]